Baillie Gifford & Co. bought a new stake in shares of Heartflow, Inc. (NASDAQ:HTFL – Free Report) in the third quarter, Holdings Channel reports. The institutional investor bought 3,005,998 shares of the company’s stock, valued at approximately $101,182,000.
Other large investors also recently bought and sold shares of the company. TFC Financial Management Inc. purchased a new stake in Heartflow during the third quarter valued at $40,000. TrueMark Investments LLC purchased a new position in shares of Heartflow in the 3rd quarter worth $918,000. Finally, Emerald Mutual Fund Advisers Trust bought a new stake in shares of Heartflow in the 3rd quarter worth about $4,418,000.
Heartflow Trading Down 4.0%
Shares of NASDAQ HTFL opened at $32.16 on Friday. Heartflow, Inc. has a 1 year low of $25.38 and a 1 year high of $41.22. The stock has a 50-day moving average price of $30.42. The company has a market capitalization of $2.74 billion and a P/E ratio of -17.77.
Wall Street Analyst Weigh In
Read Our Latest Stock Report on Heartflow
Insider Activity
In other Heartflow news, Director Jeffrey C. Lightcap acquired 40,000 shares of the company’s stock in a transaction that occurred on Tuesday, December 16th. The stock was bought at an average price of $26.34 per share, for a total transaction of $1,053,600.00. Following the acquisition, the director directly owned 40,000 shares in the company, valued at $1,053,600. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Heartflow Profile
HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.
HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.
Recommended Stories
- Five stocks we like better than Heartflow
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- The $100 Trillion AI Story No One Is Telling You
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Want to see what other hedge funds are holding HTFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Heartflow, Inc. (NASDAQ:HTFL – Free Report).
Receive News & Ratings for Heartflow Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heartflow and related companies with MarketBeat.com's FREE daily email newsletter.
